Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
Resource Type
Article
Authors
Tricou, Vianney ; Yu, Delia ; Reynales, Humberto ; Biswal, Shibadas ; Saez-Llorens, Xavier ; Sirivichayakul, Chukiat ; Lopez, Pio ; Borja-Tabora, Charissa ; Bravo, Lulu ; Kosalaraksa, Pope ; Vargas, Luis Martinez ; Alera, Maria Theresa ; Rivera, Luis ; Watanaveeradej, Veerachai ; Dietze, Reynaldo ; Fernando, LakKumar ; Wickramasinghe, V Pujitha ; Moreira, Edson Duarte, Jr ; Fernando, Asvini D ; Gunasekera, Dulanie ; Luz, Kleber ; Oliveira, Ana Lucia ; Tuboi, Suely ; Escudero, Ian ; Hutagalung, Yanee ; Lloyd, Eric ; Rauscher, Martina ; Zent, Olaf ; Folschweiller, Nicolas ; LeFevre, Inge ; Espinoza, Felix ; Wallace, Derek
Source
In The Lancet Global Health February 2024 12(2):e257-e270
Subject
Primary Research Articles
Language
ISSN
2214-109X